EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)

Shuai Liu, Shaobo Kang, Na Lin, Wenqi Zhang, Shiwen Wang, Yuqing Ren, Xiaofan Ding, Jianxiu Yu, Ruiyu Xie

Advanced Science · 2025-10 · 12 (37)

DOI: 10.1002/advs.71801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.10.2025. Verfasst von Shuai Liu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liu, S., Kang, S., Lin, N., Zhang, W., Wang, S., Ren, Y., Ding, X., Yu, J., & Xie, R. (2025). The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science, 12(37). https://doi.org/10.1002/advs.71801

Vancouver

Liu S, Kang S, Lin N, Zhang W, Wang S, Ren Y, et al. The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science. 2025;12(37). doi:10.1002/advs.71801

BibTeX
@article{Liu2025,
  author = {Liu, Shuai and Kang, Shaobo and Lin, Na and Zhang, Wenqi and Wang, Shiwen and Ren, Yuqing and Ding, Xiaofan and Yu, Jianxiu and Xie, Ruiyu},
  title = {The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {37},
  doi = {10.1002/advs.71801}
}
Kostenlos starten →